FDA approves Bristol Myers’ multiple myeloma successor

The FDA has granted accelerated approval for a Bristol Myers Squibb pill called iberdomide for patients with multiple myeloma that’s returned or stopped responding to treatment. Iberdomide is marketed as Zenbexus, and carries a list ...